文献速递传染病防控与疫情报告免疫规划

疫情背景下检测阴性设计研究的潜在偏倚:以刚果民主共和国埃博拉疫苗接种为例

Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.
PubMed 文献 · Int J Epidemiol · 2022-01-01

该研究通过建模方法量化了在疫情背景下使用检测阴性设计(TND)评估预防性疫苗效果时的偏倚。模型考虑了疫苗分配异质性及自我报告和接触者追踪两种检测招募途径,发现传统TND估计存在偏倚,而混合TND设计在记录检测途径时可消除偏倚。作者建议公共卫生应对中应收集个体的检测途径数据,并在通用研究方案中强调记录检测途径的必要性。

要点

  • 疫情中传统检测阴性设计因自我报告与接触者追踪的差异招募及疫苗接种聚集而产生偏倚。
  • 混合检测阴性设计在记录检测途径时可消除传统设计的偏倚。
  • 公共卫生应对应收集检测途径数据,通用方案应强调记录检测途径。

核心结论

  • 传统检测阴性设计在疫情背景下估计疫苗效果时存在偏倚,混合设计可消除该偏倚(若记录检测途径)。
  • 若无检测途径数据,需其他流行病学数据估计传统设计中潜在偏倚的幅度。

研究设计与样本

  • 采用建模方法量化预防性疫苗在变化的研究和流行病学场景下的检测阴性设计偏倚。
  • 模型考虑疫苗分配异质性及自我报告和接触者追踪两种检测招募途径。

主要发现

  • 传统检测阴性设计模型发现疫苗效果估计存在偏倚。
  • 偏倚源于自我报告和接触者追踪的差异招募及疫苗接种的聚集。
  • 估计了当招募途径不可用时的偏倚程度。

临床怎么用

  • 公共卫生应对应收集个体检测途径数据以支持混合检测阴性设计。
  • 通用疫情应对研究方案应强调记录检测途径的必要性。
  • 若需回顾性研究,应确保公共卫生应对中获取检测途径数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infectious disease outbreaks present unique challenges to study designs for vaccine evaluation. Test-negative design (TND) studies have previously been used to estimate vaccine effectiveness and have been proposed for Ebola virus disease (EVD) vaccines. However, there are key differences in how cases and controls are recruited during outbreaks and pandemics of novel pathogens, whcih have implications for the reliability of effectiveness estimates using this design. METHODS: We use a modelling approach to quantify TND bias for a prophylactic vaccine under varying study and epidemiological scenarios. Our model accounts for heterogeneity in vaccine distribution and for two potential routes to testing and recruitment into the study: self-reporting and contact-tracing. We derive conventional and hybrid TND estimators for this model and suggest ways to translate public health response data into the parameters of the model. RESULTS: Using a conventional TND study, our model finds biases in vaccine effectiveness estimates. Bias arises due to differential recruitment from self-reporting and contact-tracing, and due to clustering of vaccination. We estimate the degree of bias when recruitment route is not available, and propose a study design to eliminate the bias if recruitment route is recorded. CONCLUSIONS: Hybrid TND studies can resolve the design bias with conventional TND studies applied to outbreak and pandemic response testing data, if those efforts collect individuals' routes to testing. Without route to testing, other epidemiological data will be required to estimate the magnitude of potential bias in a conventional TND study. Since these studies may need to be conducted retrospectively, public health responses should obtain these data, and generic protocols for outbreak and pandemic response studies should emphasize the need to record routes to testing.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Pearson CAB, Edmunds WJ, Hladish TJ, et al. Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo. Int J Epidemiol. 2022. PMID: 34458913. doi:10.1093/ije/dyab172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。